丹尼尔斯和休斯替代终点评估的多变元元分析模型的新频率主义实现
Dan Jackson1, Michael Sweeting1, Robbie C M van Aert2
1Statistical Innovation Group, AstraZeneca, Cambridge, UK.
Biometrical journal. Biometrische Zeitschrift
|March 19, 2025
概括
研究人员开发了一种新的偏差纠正统计方法,用于评估临床试验中的代用终点. 这种频率主义方法解决了现有的贝叶斯模型的局限性,提高了在瘤学中替代终点评估的准确性.
科学领域:
- 生物统计学 生物统计学
- 临床试验方法论 临床试验方法论
- 医学研究 医学研究
背景情况:
- 当初级结果难以衡量时,替代终点对于评估治疗疗效至关重要.
- 评估替代终点的适用性需要强大的统计模型,通常采用元分析方法.
- 丹尼尔斯和休斯双变量模型是试验级替代终点评估的有希望的工具,但缺乏频率估计方法.
研究的目的:
- 为达尼尔斯和休斯双变量模型推导频率最大概率估计方程.
- 为模型的未知方差组件开发一个偏差调整的估计器,解决现有方法的局限性.
- 为替代终点评估中频率估计提供一个计算可行和直观结构化的方法.
主要方法:
- 对丹尼尔斯和休斯双变量模型的最大概率估计方程的推导.
- 对差异组件估计器的偏差校正术语的开发.
- 进行了一项模拟研究,以评估拟议的偏差调整估计器的性能.
- 这些方法用两个不同的瘤学试验示例来说明.
主要成果:
- 成功推导出双变异替代终点模型的最大概率估计方程.
- 开发了一个偏差调整的估计器,具有易于计算和代数直观的校正术语.
- 模拟研究表明,拟议的估计器有效地克服了最大概率估计的困难.
- 这种新的频率主义方法与现实世界瘤学数据得到了验证.
结论:
- 拟议的偏差调整频率估计器为丹尼尔斯和休斯双变量模型提供了现有的贝叶斯式解决方案的可行替代方案.
- 这一进步有助于更容易获得和更准确的试验级替代终点评估,特别是在瘤学等领域.
- 这种新方法提高了在临床研究中使用代用终点的可靠性.
相关概念视频
Kaplan-Meier Approach
71
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
71
Comparing the Survival Analysis of Two or More Groups
110
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
110
Censoring Survival Data
55
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
55
Mechanistic Models: Compartment Models in Individual and Population Analysis
23
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
23
Assumptions of Survival Analysis
77
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
77
Introduction To Survival Analysis
147
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
147


